Advertisement

Journal of Genetic Counseling

, Volume 18, Issue 3, pp 239–251 | Cite as

Living at Risk: The Sibling’s Perspective of Early-Onset Alzheimer’s Disease

  • Karen E. Wain
  • Wendy R. Uhlmann
  • Judith Heidebrink
  • J. Scott Roberts
Original Research

Abstract

Early-onset Alzheimer’s disease (EOAD) is an increasingly diagnosed condition and is associated with genetic risk factors. This is one of the first studies exploring the lived experience of siblings of individuals with EOAD. We used structured questionnaires and semi-structured interviews to assess a broad range of siblings’ experiences with and beliefs about EOAD, including knowledge, perceptions of personal risk, level of worry, and effects on life decisions. Participants (n = 24) were predominantly female (62.5%) and middle-aged (mean = 56.8 years; range 37–83). When asked about risk factors, genetics was cited most frequently (62.5%). Several potential means of reducing AD risk were endorsed, with 54% reporting engagement in behaviors for this purpose (e.g., keeping mentally active). Participants ranged widely in their perceived personal risk of AD (range: 0–100; mean = 35.6%), with higher perceived risk associated with worry about AD (p < 0.01). Understanding siblings’ experiences with EOAD can inform how genetic counselors and healthcare professionals work with this population to facilitate risk communication and decision-making about testing and healthcare.

Keywords

Early-onset Alzheimer’s disease Sibling Risk Lived experience Worry Genetics Decision-making 

Notes

Acknowledgements

We would like to thank the individuals who volunteered to participate in this study for their time and willingness to share their experiences. This study was supported by The Michigan Alzheimer’s Disease Research Center, NIH-NIA P50 AG08671. Funding was provided through the James V. Neel Genetic Counseling Research Fellowship, a University of Michigan Genetic Counseling Research Award, and a Rackham Graduate Student Research Grant. Additional thanks are extended to the Michigan Great Lakes and Greater Michigan Chapters of the Alzheimer’s Association.

References

  1. Alzheimer’s Association. (2006). Early-onset dementia: A national challenge, a future crisis. Accessible at www.alz.org; search “early-onset”.
  2. Alzheimer’s Association. (2007). Alzheimer’s disease facts and figures. Accessible at www.alz.org; search “facts and figures”.
  3. Beebe-Dimmer, D. L., Wood Jr, D. P., Gruber, S. B., Chilson, D. M., Zuhlke, K. A., Claeys, G. B., et al. (2004). Risk perception and concern among brothers of men with prostate carcinoma. Cancer, 100, 1537–1544. doi: 10.1002/cncr.20121.PubMedCrossRefGoogle Scholar
  4. Bertram, L., & Tanzi, R. E. (2004). The current status of Alzheimer’s disease genetics: what do we tell the patients? Pharmacological Research, 50, 385–396. doi: 10.1016/j.phrs.2003.11.018.PubMedCrossRefGoogle Scholar
  5. Bird, T. D. (2005). Genetic factors in Alzheimer’s disease. The New England Journal of Medicine, 352, 862–864. doi: 10.1056/NEJMp058027.PubMedCrossRefGoogle Scholar
  6. Brickell, K. L., Steinbart, E. J., Rumbaugh, M., Payami, H., Schellenberg, G. D., Van Deerlin, V., et al. (2006). Early-onset Alzheimer disease in families with late-onset Alzheimer disease. Archives of Neurology, 63, 1307–1311. doi: 10.1001/archneur.63.9.1307.PubMedCrossRefGoogle Scholar
  7. Broadstock, M., Michie, S., & Marteau, T. (2000). Psychological consequences of predictive genetic testing: a systematic review. European Journal of Human Genetics, 8, 731–738. doi: 10.1038/sj.ejhg.5200532.PubMedCrossRefGoogle Scholar
  8. Decruynaere, M., Evers-Kiebooms, G., Boogaerts, A., Cassiman, J. J., Cloostermans, T., Demyttenaere, K., et al. (1999). Psychological functioning before predictive testing for Huntington’s disease: the role of the parental disease, risk perception, and subjective proximity of the disease. Journal of Medical Genetics, 36, 897–905.Google Scholar
  9. Decruyenaere, M., Evers-Kiebooms, G., Weldenhuysen, M., Denayer, L., & Claes, E. (2000). Cognitive representations of breast cancer, emotional distress, and preventive health behavior: a theoretical perspective. Psycho-Oncology, 9, 528–536. doi: 10.1002/1099-1611(200011/12)9:6<528::AID-PON486>3.0.CO;2-#.PubMedCrossRefGoogle Scholar
  10. Etchegary, H. (2006). Discovering the family history of Huntington disease (HD). Journal of Genetic Counseling, 2, 105–117. doi: 10.1007/s10897-006-9018-7.CrossRefGoogle Scholar
  11. Fanos, J. H. (1999). “My crooked vision”: the well sib views Ataxia-Telangiectasia. American Journal of Medical Genetics, 87, 420–425. doi: 10.1002/(SICI)1096-8628(19991222)87:5<420::AID-AJMG9>3.0.CO;2-U.PubMedCrossRefGoogle Scholar
  12. Fanos, J. H., & Johnson, J. P. (1995). Barriers to carrier testing for adult Cystic Fibrosis sibs: the importance of not knowing. American Journal of Medical Genetics, 59, 85–91. doi: 10.1002/ajmg.1320590117.PubMedCrossRefGoogle Scholar
  13. Fanos, J. H., & Gatti, R. A. (1999). A mark on the arm: myths of carrier status in sibs of individuals with Ataxia-Telangiectasia. American Journal of Medical Genetics, 86, 338–346. doi: 10.1002/(SICI)1096-8628(19991008)86:4<338::AID-AJMG8>3.0.CO;2-F.PubMedCrossRefGoogle Scholar
  14. Fanos, J. H., Davis, J., & Puck, J. M. (2001). Sib understanding of genetics and attitudes toward carrier testing for X-Linked severe combined immunodeficiency. American Journal of Medical Genetics, 98, 46–56. doi: 10.1002/1096-8628(20010101)98:1<46::AID-AJMG1008>3.0.CO;2-K.PubMedCrossRefGoogle Scholar
  15. Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W. A., Mayeux, R., et al. (1997). Effects of age, sex, and ethnicity on the association between Apolipoprotien E Genotype and Alzheimer’s disease: a meta-analysis. Journal of the American Medical Association, 278, 1349–1356. doi: 10.1001/jama.278.16.1349.PubMedCrossRefGoogle Scholar
  16. Gershenson Hodgson, L., & Cutler, S. J. (2003). Looking for signs of Alzheimer’s disease. International Journal of Aging & Human Development, 56, 323–343. doi: 10.2190/E6J1-PUX7-J43C-090B.CrossRefGoogle Scholar
  17. Green, R. C., Cupples, L. A., Go, R., Benke, K. S., Edeki, T., Griffith, P. A., et al. (2002). Risk of dementia among white and African American relatives of patients with Alzheimer disease. Journal of the American Medical Association, 287, 329–336. doi: 10.1001/jama.287.3.329.PubMedCrossRefGoogle Scholar
  18. Heath, H., & Cowley, S. (2004). Developing a grounded theory approach: a comparison of Glaser and Strauss. International Journal of Nursing Studies, 41, 141–150. doi: 10.1016/S0020-7489(03)00113-5.PubMedCrossRefGoogle Scholar
  19. Hendrie, H. C., Albert, M. S., Butters, M. A., Gao, S., Knopman, D. S., Launer, L. J., et al. (2006). The NIH cognitive and emotional health project: report of the critical evaluation study committee. Alzheimer’s & Dementia, 2, 12–32. doi: 10.1016/j.jalz.2005.11.004.CrossRefGoogle Scholar
  20. Lautenschlager, N. T., Cupples, L. A., Rao, V. S., Auerbach, S. A., Becker, R., Burke, J., et al. (1996). Risk of dementia among relatives of Alzheimer’s disease patients in the MIRAGE study: what is in store for the oldest old? Neurology, 46, 641–650.PubMedGoogle Scholar
  21. McAllister, M., Payne, K., Nicholls, S., MacLeod, R., Donnai, D., & Davies, L. M. (2007). Improving service evaluation in clinical genetics: identifying effects of genetic diseases on individuals and families. Journal of Genetic Counseling, 16, 71–83. doi: 10.1007/s10897-006-9046-3.PubMedCrossRefGoogle Scholar
  22. Pinquart, M., & Sorensen, S. (2006). Gender differences in caregiver stressors, social resources, and health: an updated meta-analysis. Journal of Gerontology, 61B, 33–45.Google Scholar
  23. Roberts, J. S. (2000). Anticipating response to predictive genetic testing for Alzheimer’s disease: a survey of first-degree relatives. The Gerontologist, 40, 43–52.PubMedGoogle Scholar
  24. Roberts, J. S., & Connell, C. M. (2000). Illness representations among first-degree relatives of people with Alzheimer disease. Alzheimer Disease and Associated Disorders, 14, 129–136. doi: 10.1097/00002093-200007000-00003.PubMedCrossRefGoogle Scholar
  25. Roberts, J. S., Barber, M., Brown, T. M., Cupples, L. A., Farrer, L. A., LaRusse, S. A., et al. (2004). Who seeks genetic susceptibility testing for Alzheimer’s disease? findings from a multisite, randomized clinical trial. Genetics in Medicine, 6, 197–203. doi: 10.1097/01.GIM.0000132688.55591.77.PubMedCrossRefGoogle Scholar
  26. Shiloh, S. (2006). Illness representations, self-regulation, and genetic counseling: a theoretical review. Journal of Genetic Counseling, 15, 325–337. doi: 10.1007/s10897-006-9044-5.PubMedCrossRefGoogle Scholar
  27. Sivell, S., Elwyn, G., Gaff, C. L., Clarke, A. J., Iredale, R., Shaw, C., et al. (2008). How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: systematic review. Journal of Genetic Counseling, 17, 30–63. doi: 10.1007/s10897-007-9132-1.PubMedCrossRefGoogle Scholar
  28. Suhr, J. A., & Kinkela, J. H. (2007). Perceived threat of Alzheimer disease (AD): the role of personal experience with AD. Alzheimer Disease and Associated Disorders, 21, 225–231. doi: 10.1097/WAD.0b013e31813e6683.PubMedCrossRefGoogle Scholar
  29. Walter, F. M., Emery, J., Braithwaite, D., & Marteau, T. M. (2004). Lay understanding of familial risk of common chronic diseases: a systematic review and synthesis of qualitative research. Annals of Family Medicine, 2, 583–594. doi: 10.1370/afm.242.PubMedCrossRefGoogle Scholar
  30. Zick, C. D., Mathews, C. J., Roberts, J. S., Cook-Deegan, R., Pokorski, R. J., & Green, R. C. (2005). Genetic testing for Alzheimer’s disease and its impact on insurance purchasing behavior. Health Affairs, 24, 483–490. doi: 10.1377/hlthaff.24.2.483.PubMedCrossRefGoogle Scholar

Copyright information

© National Society of Genetic Counselors, Inc. 2009

Authors and Affiliations

  • Karen E. Wain
    • 1
    • 5
  • Wendy R. Uhlmann
    • 2
  • Judith Heidebrink
    • 3
  • J. Scott Roberts
    • 4
  1. 1.Department of Human GeneticsUniversity of MichiganAnn ArborUSA
  2. 2.Division of Molecular Medicine anefefd GeneticsUniversity of MichiganAnn ArborUSA
  3. 3.Department of NeurologyUniversity of MichiganAnn ArborUSA
  4. 4.Department of Health Behavior and Health EducationUniversity of MichiganAnn ArborUSA
  5. 5.Cytogenetics LaboratoryMayo ClinicRochesterUSA

Personalised recommendations